Arkuda is comprised of passionate and experienced team members who are dedicated to improving the lives of people affected by neurodegenerative disease. Armed with deep expertise in biology and the ability to understand the root cause of disease, we are discovering medicines with the potential to positively change the trajectory of neurodegeneration.

Andy Hu

Andy Hu, MD,

Chief Business Officer

Serena Hung

Serena Hung, MD,

Chief Medical Officer

Duane Burnett

Duane Burnett, PhD,

Chief Technology Officer

Gerhard Koenig


Co-founder, President and CEO

Betsy Kassler,

Senior Director, Human Resources

Raymond Hurst, PhD,

Senior Vice President, Discovery

Mike Esposito, MSF,

Vice President, Finance

Irena Webster, MPH,

Vice President, Program Strategy & Dev Ops

Anna-Maria Alves, MS,

Associate Scientist

Giuseppe Astarita, PhD,

Senior Director, Biomarker Dx

Jean Francois Blain

Jean-François Blain, PhD,

Vice President, Neurobiology

Morgan Brand, PhD,

Associate Scientist

Angela Chen

Angela Chen, MS,

Scientist II

Richard Gallegos,

Principal Scientist, DMPK

Gennifer Greenberg,

Senior Research Associate

Shawna Henry, PhD,

Scientist I

Christopher Holler

Christopher Holler, PhD,

Principal Scientist

Deliwe Jalbert, MBA,

Executive Assistant

Jim Lanter, PhD,

Vice President, Medicinal Chemistry

Stephanie McTighe, PhD,

Director, Pharmacology

Ingrid Ochoa,

Lab/Facility Manager

Xiaowen Peng, PhD,

Director, Medicinal Chemistry

Denise Peters,

Accounting Controller

John Ross, MS, RLATG, DSP, DABT,

Associate Director, Toxicology

Bonne Thompson,

Scientist II, Mass Spectrometry

Hillary Van Voorhies, MS,

Director, Program Management

Katie Watters, PhD,

Scientist I

Mary Wozniak,

Senior Research Associate